Team:Carnegie Mellon/Bio-Submitted

From 2012.igem.org

(Difference between revisions)
Line 100: Line 100:
<div id="toc-holder" class="toc-holder">
<div id="toc-holder" class="toc-holder">
<a href="#" class="toc-link" id="toc-link"><span>&#9660;</span> Table of Contents</a>
<a href="#" class="toc-link" id="toc-link"><span>&#9660;</span> Table of Contents</a>
-
<ul id="toc" class="toc" style="background: #ac9d74;">
+
<ul id="toc" class="toc-new" style="background: #c1a562;">
<li class="toc-h1"><a href="#section1">Submitted Parts</a>
<li class="toc-h1"><a href="#section1">Submitted Parts</a>
<ul class="toc-sub closed">
<ul class="toc-sub closed">

Revision as of 00:16, 16 September 2012

Image:CMU_image6.jpeg




Submitted Parts

BBa_K613007: TAATACGACTCACTATAGGGAGAGGAATTGTGAGCGGATAACAA
Mutant I: TAATGCGACTCACTATAGGACAATTGTGGGCGGACAACAATTCCAA
Mutant II: CAATACGACTCACTATAGGGCAATTGTGAGCGCTCACAATTGCAA
Mutant III: TAATACGACTCACTACAGGGCGGAATTGTGAGCGGATAACAATTCCAA
Mutant IV: CAATCCGACTCACTAAAGAGAGAATTGTGAGCGGATAACAATTCCAA

Hypothesis:

Expected promoter strength of different mutants:
Mutant I: <100%
Mutant II: >>100%
Mutant III: ~100%
Mutant IV: ~50%

Expected LacI leaky expression of different mutants:
Mutant I: More than average
Mutant II: Below average
Mutant III: Average
Mutant IV: Average

Image:TartanFooter.jpeg